Itron (NASDAQ:ITRI) Rating Reiterated by Roth Mkm

Roth Mkm restated their buy rating on shares of Itron (NASDAQ:ITRI) in a report published on Tuesday, Benzinga reports. They currently have a $102.00 target price on the scientific and technical instruments company’s stock.

Several other equities research analysts also recently weighed in on ITRI. TheStreet raised shares of Itron from a c rating to a b- rating in a research report on Monday, February 26th. TD Cowen boosted their target price on shares of Itron from $107.00 to $110.00 and gave the stock an outperform rating in a research report on Wednesday, March 13th. Canaccord Genuity Group raised shares of Itron from a hold rating to a buy rating and boosted their price objective for the company from $68.00 to $105.00 in a research report on Tuesday, February 27th. Piper Sandler lowered their price objective on shares of Itron from $105.00 to $103.00 and set an overweight rating for the company in a research report on Thursday, April 11th. Finally, Robert W. Baird boosted their price objective on shares of Itron from $108.00 to $115.00 and gave the company an outperform rating in a research report on Wednesday, March 13th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, Itron has an average rating of Moderate Buy and an average target price of $97.60.

Itron Stock Performance

Itron stock opened at $94.39 on Tuesday. Itron has a 12-month low of $50.60 and a 12-month high of $96.73. The company has a market capitalization of $4.33 billion, a price-to-earnings ratio of 44.95, a price-to-earnings-growth ratio of 1.05 and a beta of 1.41. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.43. The firm’s fifty day moving average price is $89.03 and its 200 day moving average price is $75.65.

Itron (NASDAQ:ITRI) last released its earnings results on Monday, February 26th. The scientific and technical instruments company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.48. The company had revenue of $577.17 million during the quarter, compared to the consensus estimate of $569.90 million. Itron had a net margin of 4.46% and a return on equity of 12.27%. The company’s revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.71 EPS. On average, research analysts forecast that Itron will post 3.61 EPS for the current fiscal year.

Insider Buying and Selling at Itron

In other Itron news, Director Jerome J. Lande sold 14,896 shares of the business’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $95.25, for a total transaction of $1,418,844.00. Following the completion of the transaction, the director now directly owns 5,750 shares of the company’s stock, valued at approximately $547,687.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Donald L. Reeves III sold 502 shares of the company’s stock in a transaction that occurred on Wednesday, February 28th. The shares were sold at an average price of $91.02, for a total value of $45,692.04. Following the completion of the sale, the senior vice president now directly owns 16,427 shares of the company’s stock, valued at approximately $1,495,185.54. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jerome J. Lande sold 14,896 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $95.25, for a total transaction of $1,418,844.00. Following the completion of the sale, the director now directly owns 5,750 shares of the company’s stock, valued at $547,687.50. The disclosure for this sale can be found here. Insiders sold 30,467 shares of company stock valued at $2,752,520 in the last ninety days. Company insiders own 1.45% of the company’s stock.

Institutional Trading of Itron

A number of institutional investors have recently made changes to their positions in ITRI. GAMMA Investing LLC acquired a new stake in shares of Itron in the 4th quarter worth approximately $27,000. Contravisory Investment Management Inc. lifted its stake in shares of Itron by 61.5% in the 1st quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock worth $32,000 after acquiring an additional 131 shares during the period. Covestor Ltd lifted its stake in shares of Itron by 9,150.0% in the 3rd quarter. Covestor Ltd now owns 555 shares of the scientific and technical instruments company’s stock worth $34,000 after acquiring an additional 549 shares during the period. Harvest Fund Management Co. Ltd acquired a new stake in shares of Itron in the 4th quarter worth approximately $50,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Itron in the 4th quarter worth approximately $76,000. 96.19% of the stock is owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.